Cure My Disease

Don't miss your cure!

 Log in / Sign up

Special forces veterans test Psychedelic-Device combo for PTSD and brain injury

NCT ID NCT07717866

Ongoing Disease control Sponsor: Axial Therapeutic Research Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study looks at whether a combination of ibogaine-magnesium, 5-MeO-DMT, magnetic e-Resonance therapy (MeRT), and physiological supplements can help special operations veterans with PTSD, depression, suicidal thoughts, and cognitive problems from traumatic brain injury. Participants receive these treatments in a specific order and are followed for a year. The goal is to see if this multi-pronged approach improves symptoms and brain function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a combination of ibogaine-magnesium, 5-MeO-DMT, magnetic e-Resonance therapy (MeRT), and physiological supplements
What this could lead to
If successful, this combination approach could offer a new way to reduce PTSD, depression, and cognitive problems in veterans who have not responded to standard treatments.
What could go wrong
This is an early observational study with no control group, so results may be due to placebo or other factors. The treatments also carry risks, including heart issues and psychological distress.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain injury cognitive disorder Cognitive Dysfunction combat disorder Depression major depressive disorder post-traumatic stress disorder Suicidal Ideation traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN INJURY COGNITIVE DYSFUNCTION DEPRESSION - MAJOR DEPRESSIVE DISORDER PTSD - POST TRAUMATIC STRESS DISORDER SUICIDAL IDEATION

Contacts and locations

Locations

  • Axial Therapeutic Research

    Northridge, California, 91325, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.